Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00009646 · ClinicalTrials.gov registry record · Phase 3
Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)
A Phase 3 study, sponsored by NICHD Neonatal Research Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,202
- Enrollment target
NCT00009646 is a Phase 3 study that has completed, run by NICHD Neonatal Research Network. The registered enrollment target is 1,202 participants.
The verdict
NCT00009646, a Phase 3 study, has completed, sponsored by NICHD Neonatal Research Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,202 participants
- Enrollment target
Study Summary
This trial was to determine whether giving low-dose indomethacin to infants weight 500 to 999 grams (approximately 1 to 2 pounds) at birth improves their survival without cerebral palsy or developmental problems at 18 to 22 months of age.
Interventions
- DRUG Placebo
- DRUG Indomethacin
- DRUG indomethacin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,202 participants |
| Start Date | 1993-11 |
| Est. Completion | 2001-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00009646
The ClinicalTrials.gov registry entry for NCT00009646 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1,202 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NICHD Neonatal Research Network, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00009646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00009646 about?
NCT00009646 is a clinical study titled "Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)". This trial was to determine whether giving low-dose indomethacin to infants weight 500 to 999 grams (approximately 1 to 2 pounds) at birth improves their survival without cerebral palsy or developmental problems at 18 to 22 months of age.
What is the current status of trial NCT00009646?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,202 participants. The study started on 1993-11. Estimated completion is 2001-03.
What interventions are being tested in trial NCT00009646?
The interventions under investigation include: Placebo (DRUG), Indomethacin (DRUG), indomethacin (DRUG).
Who is sponsoring clinical trial NCT00009646?
This trial is sponsored by NICHD Neonatal Research Network, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.